ADMA Biologics, Inc. Stock News

ADMA stock rocketed Friday after the biotech company inked a deal with KPMG as its new independent registered public accounting firm. The post ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle appeared first on Investor's Business Daily.

RAMSEY, N.J. and BOCA RATON, Fla.

BOSTON, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ADMA Biologics, Inc. (Nasdaq: ADMA) for potential securities law violations. Investors who have lost money in their ADMA Biologics investment should contact the firm to learn more about how they might recover those losses.

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ:ADMA) on behalf of ADMA Biologics stockholders. Our investigation concerns whether ADMA Biologics has violated the federal securities laws and/or engaged in other u...

SAN DIEGO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether ADMA Biologics, Inc. (NASDAQ: ADMA) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered u...

BOSTON, MA / ACCESSWIRE / October 11, 2024 / Block & Leviton is investigating ADMA Biologics, Inc. (Nasdaq:ADMA) for potential securities law violations. Investors who have lost money in their ADMA Biologics investment should contact the firm to learn more about how they might recover those losses.

Investors can contact the law firm at no cost to learn more about recovering their losses

Block & Leviton is investigating ADMA Biologics for potential securities law violations. Investors who have lost money in ADMA should contact the firm.